Concord offers world-class API production infrastructure at Dholka located near Ahmedabad, Gujarat, India which is spread across 114,000 sq. meters. Concord is a hub for the largest number of Bioreactors in India with a fermentation capacity of more than 500 m3. The manufacturing facility complies with cGMP and has been Inspected by global regulatory agencies like the U.S. Food & Drug Administration (USFDA), European Union Goods Manufacturing Practice (EUGMP), Japanese Accreditation of Foreign Manufacturers (AFM), Korean Food & Drug Administration & State Goods Manufacturing Practice of India (GMP). Concord has commercialized APIs across niche therapeutic segments like Immunosuppressant, Hematology, Oncology, Anti-fungal, Antibacterial and Anthelmintic (Animal health).
A state-of-the-art formulation development & manufacturing facility spread over 95000 Sq. meters at Valthera, located near Ahmedabad, India was commissioned in 2016 to manufacture pharmaceutical dosage forms like solid orals, oral liquid and suspensions, complying with global regulatory norms. The core focus is inclined towards finished formulations into highly specialized niche segments like Immunology, Nephrology, Oncology, Critical Care and Hematology.